Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity
Crossref DOI link: https://doi.org/10.1007/s12072-014-9552-6
Published Online: 2014-07-09
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burman, Blaire E.
Kwo, Paul Y.
Kowdley, Kris V.
Text and Data Mining valid from 2014-07-01
Version of Record valid from 2014-07-01
Article History
Received: 5 March 2014
Accepted: 16 June 2014
First Online: 9 July 2014
Free to read: This content has been made available to all.